OKYO Pharma Statistics Share Statistics OKYO Pharma has 37.61M
shares outstanding. The number of shares has increased by 10.44%
in one year.
Shares Outstanding 37.61M Shares Change (YoY) 10.44% Shares Change (QoQ) 10.44% Owned by Institutions (%) 0.13% Shares Floating 23.7M Failed to Deliver (FTD) Shares 2,508 FTD / Avg. Volume 1.28%
Short Selling Information The latest short interest is 92.05K, so 0.24% of the outstanding
shares have been sold short.
Short Interest 92.05K Short % of Shares Out 0.24% Short % of Float 0.34% Short Ratio (days to cover) 1.29
Valuation Ratios PE Ratio 0 Forward PE -23 PS Ratio 0 Forward PS n/a PB Ratio 0 P/FCF Ratio 0 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for OKYO Pharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.4,
with a Debt / Equity ratio of 0.
Current Ratio 0.4 Quick Ratio 0.4 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-5.61K Employee Count 3 Asset Turnover n/a Inventory Turnover n/a
Taxes Income Tax 22.42 Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 216.27% in the
last 52 weeks. The beta is -4.2, so OKYO Pharma's
price volatility has been lower than the market average.
Beta -4.2 52-Week Price Change 216.27% 50-Day Moving Average 2.58 200-Day Moving Average 1.56 Relative Strength Index (RSI) 65.72 Average Volume (20 Days) 196,225
Income Statement
Revenue n/a Gross Profit -7.51K Operating Income -15.75K Net Income -16.83K EBITDA -15.75K EBIT -15.75K Earnings Per Share (EPS) 0
Full Income Statement Balance Sheet The company has 1.56M in cash and 0 in
debt, giving a net cash position of 1.56M.
Cash & Cash Equivalents 1.56M Total Debt n/a Net Cash n/a Retained Earnings -143.02M Total Assets 3.68M Working Capital -5.55M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -1.81M
and capital expenditures -1.21K, giving a free cash flow of -1.81M.
Operating Cash Flow -1.81M Capital Expenditures -1.21K Free Cash Flow -1.81M FCF Per Share 0
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
